Group 1 - The core viewpoint of the news is the performance and financial status of He Eye Hospital Group, which saw a stock price increase of 5.52% to 23.33 CNY per share, with a total market capitalization of 3.687 billion CNY [1] - He Eye Hospital Group was established on October 15, 2009, and went public on March 22, 2022, primarily providing specialized ophthalmic diagnosis and treatment services, with medical services accounting for 69.15% of revenue, optical services for 30.24%, and other services for 0.61% [1] - The top circulating shareholder, Rongtong Fund, reduced its holdings in He Eye Hospital by 1.7584 million shares, now holding 2.7947 million shares, which represents 3.36% of the circulating shares [2] Group 2 - Rongtong Health Industry Flexible Allocation Mixed A/B Fund (000727) has achieved a year-to-date return of 21.07% and a one-year return of 41.78%, ranking 3789 out of 8254 and 3412 out of 8037 respectively [2] - The fund manager, Wan Minyuan, has a tenure of 9 years and 9 days, with the fund's total asset size at 4.223 billion CNY and a best return of 156.58% during his tenure [3]
何氏眼科股价涨5.52%,融通基金旗下1只基金位居十大流通股东,持有279.47万股浮盈赚取340.95万元